Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Clinical trial

NCT03147287

1 development in the corpus

NCT03147287

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

SEP 11, 2026 · PHASE 2 TRIAL

Palbociclib After CDK and Endocrine Therapy (PACE)

ClinicalTrials.gov

This is a Phase 2 interventional trial with planned enrollment of 220 participants studying drug combinations for metastatic breast cancer; results are not reported in this registry record.

PreliminaryDana-Farber Cancer Institute Palbociclib Metastatic Breast Cancer

Reported

Planned enrollment220

PhasePhase 2

Primary outcome measureProgression-Free Survival (PFS) according t…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support